China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA: 600062)
China flag China · Delayed Price · Currency is CNY
21.73
-0.25 (-1.14%)
Nov 13, 2024, 3:00 PM CST

China Resources Double-Crane Pharmaceutical Co.,Ltd. Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Operating Revenue
10,21410,1149,5229,0348,3919,157
Upgrade
Other Revenue
108.38108.38102.9977.88112.69224.33
Upgrade
Revenue
10,32210,2229,6259,1128,5049,381
Upgrade
Revenue Growth (YoY)
-5.44%6.20%5.64%7.14%-9.35%14.05%
Upgrade
Cost of Revenue
4,5354,6074,3074,0483,1573,450
Upgrade
Gross Profit
5,7875,6155,3185,0645,3475,931
Upgrade
Selling, General & Admin
3,6803,4703,4783,5023,7644,354
Upgrade
Research & Development
620.72561.46482.48409.59291.02202.01
Upgrade
Other Operating Expenses
78.4298.3119.35115.75114.41136.87
Upgrade
Operating Expenses
4,3634,1394,0814,0294,1734,700
Upgrade
Operating Income
1,4241,4771,2371,0341,1731,231
Upgrade
Interest Expense
-11.8-14.07-10.62-11.62-3.66-9.5
Upgrade
Interest & Investment Income
41.5552.9389.6881.5551.3328.82
Upgrade
Earnings From Equity Investments
66.2612.5516.23---
Upgrade
Currency Exchange Gain (Loss)
6.326.3218.06-4.97-0.480.1
Upgrade
Other Non Operating Income (Expenses)
40.345.726.360.26-10.33-3.55
Upgrade
EBT Excluding Unusual Items
1,5671,5401,3571,0991,2101,247
Upgrade
Impairment of Goodwill
-28.9-28.9--56.68-43.42-24.54
Upgrade
Gain (Loss) on Sale of Investments
2.7913.85.9935.3629.0528.63
Upgrade
Gain (Loss) on Sale of Assets
-0.13-0.06-2.271.03-22.52-15.86
Upgrade
Asset Writedown
-89.14-50.63-8.43-0.54-0.12-27.58
Upgrade
Other Unusual Items
92.3592.3582.7642.6541.9254.48
Upgrade
Pretax Income
1,5431,5671,4351,1211,2151,262
Upgrade
Income Tax Expense
189.53240.61201.27149.06201.52195.34
Upgrade
Earnings From Continuing Operations
1,3541,3261,234972.131,0131,066
Upgrade
Minority Interest in Earnings
-6.117.12-53.59-36.45-8.33-11.33
Upgrade
Net Income
1,3481,3331,180935.691,0051,055
Upgrade
Net Income to Common
1,3481,3331,180935.691,0051,055
Upgrade
Net Income Growth
-14.89%12.96%26.12%-6.91%-4.74%8.93%
Upgrade
Shares Outstanding (Basic)
1,0271,0251,0361,0431,0431,043
Upgrade
Shares Outstanding (Diluted)
1,0271,0251,0361,0431,0431,043
Upgrade
Shares Change (YoY)
-0.71%-0.99%-0.74%0.00%0.00%-0.01%
Upgrade
EPS (Basic)
1.311.301.140.900.961.01
Upgrade
EPS (Diluted)
1.311.301.140.900.961.01
Upgrade
EPS Growth
-14.28%14.09%27.06%-6.91%-4.74%8.94%
Upgrade
Free Cash Flow
1,0821,026889.57849.251,0121,198
Upgrade
Free Cash Flow Per Share
1.051.000.860.810.971.15
Upgrade
Dividend Per Share
0.3570.2570.5780.4800.2900.304
Upgrade
Dividend Growth
23.53%-55.54%20.42%65.52%-4.61%8.96%
Upgrade
Gross Margin
56.06%54.93%55.25%55.57%62.87%63.22%
Upgrade
Operating Margin
13.79%14.44%12.85%11.35%13.80%13.12%
Upgrade
Profit Margin
13.06%13.04%12.26%10.27%11.82%11.25%
Upgrade
Free Cash Flow Margin
10.48%10.04%9.24%9.32%11.90%12.77%
Upgrade
EBITDA
2,0952,0921,7781,4821,5481,591
Upgrade
EBITDA Margin
20.30%20.46%18.47%16.26%18.20%16.96%
Upgrade
D&A For EBITDA
671.51615.3540.36447.4374.36360.34
Upgrade
EBIT
1,4241,4771,2371,0341,1731,231
Upgrade
EBIT Margin
13.79%14.44%12.85%11.35%13.80%13.12%
Upgrade
Effective Tax Rate
12.28%15.36%14.03%13.29%16.59%15.48%
Upgrade
Revenue as Reported
10,32210,2229,6259,1128,5049,381
Upgrade
Advertising Expenses
----45.64104.09
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.